FDA Draft Guidance Calls for Early Correspondence to Speed ANDA Review By Sam | June 19, 2017 The FDA is proposing to shorten ANDA review timelines for certain generics sponsors that submit advance information to the agency. Source: Drug Industry Daily Posted in Drug Industry Daily